Asset profile
RC220 · Rithm Acquisition (RAC)
- Indication
- EGFR-mutant non-small cell lung cancer
- Also known as
- (E,E)-bisantrene
On the calendar
Nothing scheduled in this window.
Timeline
Newest first.
Oct 12, 2026
07:00 PM
RACRithm AcquisitionRacura Oncology clears RC220 dose escalation to 100 mg/m2 in HARNESS-1 Phase 1 trial